Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107866

Enhanced Phagocytic Capacity THE BIOLOGIC BASIS FOR THE ELEVATED HISTOCHEMICAL NITROBLUE TETRAZOLIUM REACTION

Charles E. McCall, Lawrence R. DeChatelet, Robert Butler, and David Brown

Department of Medicine, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Biochemistry, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Royal Postgraduate Medical School, London

Find articles by McCall, C. in: PubMed | Google Scholar

Department of Medicine, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Biochemistry, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Royal Postgraduate Medical School, London

Find articles by DeChatelet, L. in: PubMed | Google Scholar

Department of Medicine, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Biochemistry, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Royal Postgraduate Medical School, London

Find articles by Butler, R. in: PubMed | Google Scholar

Department of Medicine, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Biochemistry, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27103

Department of Immunology, Royal Postgraduate Medical School, London

Find articles by Brown, D. in: PubMed | Google Scholar

Published November 1, 1974 - More info

Published in Volume 54, Issue 5 on November 1, 1974
J Clin Invest. 1974;54(5):1227–1234. https://doi.org/10.1172/JCI107866.
© 1974 The American Society for Clinical Investigation
Published November 1, 1974 - Version history
View PDF
Abstract

The biologic basis for the elevated histochemical reduction of nitroblue tetrazolium dye (NBT) in neutrophils from patients with acute bacterial infection or polycythemia vera was studied. A precipitin reaction followed mixing NBT with heparin. NBT was reduced after phagocytosis of this complex (H-NBT) by polymorphonuclear leukocytes (PMNs). Ingestion required divalent cations and was facilitated by the presence of complement. H-NBT incubated with normal but not with C2-deficient human serum converted native C3 to its inactive form.

Phagocytic indices were determined in patients and controls by measuring O2 utilization and hexose monophosphate shunt activity and by visually counting cell-associated latex particles. Significant elevations above controls were observed in phagocytes isolated from all patients with elevated histochemical NBT scores when H-NBT complex, latex, or zymosan was employed as the phagocytic particle. Increased indices were observed in the presence of fresh AB serum, heat-inactivated AB serum, or without serum. Serum from patients with elevated NBT scores did not alter phagocytosis in control phagocytes. With NADH and NADPH as substrates, total NBT diaphorase activity of sonicated leukocytes was normal in all patients.

These results suggest that increased phagocytic capacity of PMNs is the primary cause of increased histochemical NBT reduction. The PMNs of patients with acute bacterial infection or polycythemia vera may have alterations in their cell membranes which lead to an enhanced rate of phagocytosis.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1227
page 1227
icon of scanned page 1228
page 1228
icon of scanned page 1229
page 1229
icon of scanned page 1230
page 1230
icon of scanned page 1231
page 1231
icon of scanned page 1232
page 1232
icon of scanned page 1233
page 1233
icon of scanned page 1234
page 1234
Version history
  • Version 1 (November 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts